The pregnancy in polycystic ovary syndrome II study: Baseline characteristics and effects of obesity from a multicenter randomized clinical trial

Richard S. Legro, Robert G. Brzyski, Michael Peter Diamond, Christos Coutifaris, William D. Schlaff, Ruben Alvero, Peter Casson, Gregory M. Christman, Hao Huang, Qingshang Yan, Daniel J. Haisenleder, Kurt T. Barnhart, G. Wright Bates, Rebecca Usadi, Richard Lucidi, Valerie Baker, J. C. Trussell, Stephen A. Krawetz, Peter Snyder, Dana OhlNanette Santoro, Esther Eisenberg, Heping Zhang

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

Objective To summarize baseline characteristics from a large multicenter infertility clinical trial. Design Cross-sectional baseline data from a double-blind randomized trial of two treatment regimens (letrozole vs. clomiphene). Setting Academic Health Centers throughout the United States. Patient(s) Seven hundred fifty women with polycystic ovary syndrome (PCOS) and their male partners took part in the study. Intervention(s) None. Main Outcome Measure(s) Historic, biometric, biochemical, and questionnaire parameters. Result(s) Females averaged 30 years and were obese (body mass index [BMI] 35) with ∼20% from a racial/ethnic minority. Most (87%) were hirsute and nulligravid (63%). Most of the women had an elevated antral follicle count and enlarged ovarian volume on ultrasound. Women had elevated mean circulating androgens, LH-to-FSH ratio (∼2), and antimüllerian hormone levels (8.0 ng/mL). In addition, women had evidence for metabolic dysfunction with elevated mean fasting insulin and dyslipidemia. Increasing obesity was associated with decreased LH-to-FSH levels, antimüllerian hormone levels, and antral follicle counts but increasing cardiovascular risk factors, including prevalence of the metabolic syndrome. Men were obese (BMI 30) and had normal mean semen parameters. Conclusion(s) The treatment groups were well matched at baseline. Obesity exacerbates select female reproductive and most metabolic parameters. We have also established a database and sample repository that will eventually be accessible to investigators. Clinical Trial Registration Number NCT00719186.

Original languageEnglish (US)
JournalFertility and sterility
Volume101
Issue number1
DOIs
StatePublished - Jan 1 2014

Fingerprint

Polycystic Ovary Syndrome
Randomized Controlled Trials
Obesity
Pregnancy
letrozole
Body Mass Index
Clinical Trials
Hormones
Clomiphene
Dyslipidemias
Semen
Infertility
Androgens
Fasting
Research Personnel
Outcome Assessment (Health Care)
Databases
Insulin
Health
Therapeutics

Keywords

  • Insulin resistance
  • hirsutism
  • infertility
  • metabolic syndrome
  • ovulation induction

ASJC Scopus subject areas

  • Reproductive Medicine
  • Obstetrics and Gynecology

Cite this

The pregnancy in polycystic ovary syndrome II study : Baseline characteristics and effects of obesity from a multicenter randomized clinical trial. / Legro, Richard S.; Brzyski, Robert G.; Diamond, Michael Peter; Coutifaris, Christos; Schlaff, William D.; Alvero, Ruben; Casson, Peter; Christman, Gregory M.; Huang, Hao; Yan, Qingshang; Haisenleder, Daniel J.; Barnhart, Kurt T.; Bates, G. Wright; Usadi, Rebecca; Lucidi, Richard; Baker, Valerie; Trussell, J. C.; Krawetz, Stephen A.; Snyder, Peter; Ohl, Dana; Santoro, Nanette; Eisenberg, Esther; Zhang, Heping.

In: Fertility and sterility, Vol. 101, No. 1, 01.01.2014.

Research output: Contribution to journalArticle

Legro, RS, Brzyski, RG, Diamond, MP, Coutifaris, C, Schlaff, WD, Alvero, R, Casson, P, Christman, GM, Huang, H, Yan, Q, Haisenleder, DJ, Barnhart, KT, Bates, GW, Usadi, R, Lucidi, R, Baker, V, Trussell, JC, Krawetz, SA, Snyder, P, Ohl, D, Santoro, N, Eisenberg, E & Zhang, H 2014, 'The pregnancy in polycystic ovary syndrome II study: Baseline characteristics and effects of obesity from a multicenter randomized clinical trial', Fertility and sterility, vol. 101, no. 1. https://doi.org/10.1016/j.fertnstert.2013.08.056
Legro, Richard S. ; Brzyski, Robert G. ; Diamond, Michael Peter ; Coutifaris, Christos ; Schlaff, William D. ; Alvero, Ruben ; Casson, Peter ; Christman, Gregory M. ; Huang, Hao ; Yan, Qingshang ; Haisenleder, Daniel J. ; Barnhart, Kurt T. ; Bates, G. Wright ; Usadi, Rebecca ; Lucidi, Richard ; Baker, Valerie ; Trussell, J. C. ; Krawetz, Stephen A. ; Snyder, Peter ; Ohl, Dana ; Santoro, Nanette ; Eisenberg, Esther ; Zhang, Heping. / The pregnancy in polycystic ovary syndrome II study : Baseline characteristics and effects of obesity from a multicenter randomized clinical trial. In: Fertility and sterility. 2014 ; Vol. 101, No. 1.
@article{152172c14a03473f9613e8fd0f8e215e,
title = "The pregnancy in polycystic ovary syndrome II study: Baseline characteristics and effects of obesity from a multicenter randomized clinical trial",
abstract = "Objective To summarize baseline characteristics from a large multicenter infertility clinical trial. Design Cross-sectional baseline data from a double-blind randomized trial of two treatment regimens (letrozole vs. clomiphene). Setting Academic Health Centers throughout the United States. Patient(s) Seven hundred fifty women with polycystic ovary syndrome (PCOS) and their male partners took part in the study. Intervention(s) None. Main Outcome Measure(s) Historic, biometric, biochemical, and questionnaire parameters. Result(s) Females averaged 30 years and were obese (body mass index [BMI] 35) with ∼20{\%} from a racial/ethnic minority. Most (87{\%}) were hirsute and nulligravid (63{\%}). Most of the women had an elevated antral follicle count and enlarged ovarian volume on ultrasound. Women had elevated mean circulating androgens, LH-to-FSH ratio (∼2), and antim{\"u}llerian hormone levels (8.0 ng/mL). In addition, women had evidence for metabolic dysfunction with elevated mean fasting insulin and dyslipidemia. Increasing obesity was associated with decreased LH-to-FSH levels, antim{\"u}llerian hormone levels, and antral follicle counts but increasing cardiovascular risk factors, including prevalence of the metabolic syndrome. Men were obese (BMI 30) and had normal mean semen parameters. Conclusion(s) The treatment groups were well matched at baseline. Obesity exacerbates select female reproductive and most metabolic parameters. We have also established a database and sample repository that will eventually be accessible to investigators. Clinical Trial Registration Number NCT00719186.",
keywords = "Insulin resistance, hirsutism, infertility, metabolic syndrome, ovulation induction",
author = "Legro, {Richard S.} and Brzyski, {Robert G.} and Diamond, {Michael Peter} and Christos Coutifaris and Schlaff, {William D.} and Ruben Alvero and Peter Casson and Christman, {Gregory M.} and Hao Huang and Qingshang Yan and Haisenleder, {Daniel J.} and Barnhart, {Kurt T.} and Bates, {G. Wright} and Rebecca Usadi and Richard Lucidi and Valerie Baker and Trussell, {J. C.} and Krawetz, {Stephen A.} and Peter Snyder and Dana Ohl and Nanette Santoro and Esther Eisenberg and Heping Zhang",
year = "2014",
month = "1",
day = "1",
doi = "10.1016/j.fertnstert.2013.08.056",
language = "English (US)",
volume = "101",
journal = "Fertility and Sterility",
issn = "0015-0282",
publisher = "Elsevier Inc.",
number = "1",

}

TY - JOUR

T1 - The pregnancy in polycystic ovary syndrome II study

T2 - Baseline characteristics and effects of obesity from a multicenter randomized clinical trial

AU - Legro, Richard S.

AU - Brzyski, Robert G.

AU - Diamond, Michael Peter

AU - Coutifaris, Christos

AU - Schlaff, William D.

AU - Alvero, Ruben

AU - Casson, Peter

AU - Christman, Gregory M.

AU - Huang, Hao

AU - Yan, Qingshang

AU - Haisenleder, Daniel J.

AU - Barnhart, Kurt T.

AU - Bates, G. Wright

AU - Usadi, Rebecca

AU - Lucidi, Richard

AU - Baker, Valerie

AU - Trussell, J. C.

AU - Krawetz, Stephen A.

AU - Snyder, Peter

AU - Ohl, Dana

AU - Santoro, Nanette

AU - Eisenberg, Esther

AU - Zhang, Heping

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Objective To summarize baseline characteristics from a large multicenter infertility clinical trial. Design Cross-sectional baseline data from a double-blind randomized trial of two treatment regimens (letrozole vs. clomiphene). Setting Academic Health Centers throughout the United States. Patient(s) Seven hundred fifty women with polycystic ovary syndrome (PCOS) and their male partners took part in the study. Intervention(s) None. Main Outcome Measure(s) Historic, biometric, biochemical, and questionnaire parameters. Result(s) Females averaged 30 years and were obese (body mass index [BMI] 35) with ∼20% from a racial/ethnic minority. Most (87%) were hirsute and nulligravid (63%). Most of the women had an elevated antral follicle count and enlarged ovarian volume on ultrasound. Women had elevated mean circulating androgens, LH-to-FSH ratio (∼2), and antimüllerian hormone levels (8.0 ng/mL). In addition, women had evidence for metabolic dysfunction with elevated mean fasting insulin and dyslipidemia. Increasing obesity was associated with decreased LH-to-FSH levels, antimüllerian hormone levels, and antral follicle counts but increasing cardiovascular risk factors, including prevalence of the metabolic syndrome. Men were obese (BMI 30) and had normal mean semen parameters. Conclusion(s) The treatment groups were well matched at baseline. Obesity exacerbates select female reproductive and most metabolic parameters. We have also established a database and sample repository that will eventually be accessible to investigators. Clinical Trial Registration Number NCT00719186.

AB - Objective To summarize baseline characteristics from a large multicenter infertility clinical trial. Design Cross-sectional baseline data from a double-blind randomized trial of two treatment regimens (letrozole vs. clomiphene). Setting Academic Health Centers throughout the United States. Patient(s) Seven hundred fifty women with polycystic ovary syndrome (PCOS) and their male partners took part in the study. Intervention(s) None. Main Outcome Measure(s) Historic, biometric, biochemical, and questionnaire parameters. Result(s) Females averaged 30 years and were obese (body mass index [BMI] 35) with ∼20% from a racial/ethnic minority. Most (87%) were hirsute and nulligravid (63%). Most of the women had an elevated antral follicle count and enlarged ovarian volume on ultrasound. Women had elevated mean circulating androgens, LH-to-FSH ratio (∼2), and antimüllerian hormone levels (8.0 ng/mL). In addition, women had evidence for metabolic dysfunction with elevated mean fasting insulin and dyslipidemia. Increasing obesity was associated with decreased LH-to-FSH levels, antimüllerian hormone levels, and antral follicle counts but increasing cardiovascular risk factors, including prevalence of the metabolic syndrome. Men were obese (BMI 30) and had normal mean semen parameters. Conclusion(s) The treatment groups were well matched at baseline. Obesity exacerbates select female reproductive and most metabolic parameters. We have also established a database and sample repository that will eventually be accessible to investigators. Clinical Trial Registration Number NCT00719186.

KW - Insulin resistance

KW - hirsutism

KW - infertility

KW - metabolic syndrome

KW - ovulation induction

UR - http://www.scopus.com/inward/record.url?scp=84891557755&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84891557755&partnerID=8YFLogxK

U2 - 10.1016/j.fertnstert.2013.08.056

DO - 10.1016/j.fertnstert.2013.08.056

M3 - Article

AN - SCOPUS:84891557755

VL - 101

JO - Fertility and Sterility

JF - Fertility and Sterility

SN - 0015-0282

IS - 1

ER -